Works matching IS 09395555 AND DT 2002 AND VI 81 AND IP 7


Results: 15
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.

    Published in:
    Annals of Hematology, 2002, v. 81, n. 7, p. 362, doi. 10.1007/s00277-002-0480-5
    By:
    • Vela-Ojeda, J.;
    • García-Ruiz Esparza, M. A.;
    • Rosas-Cabral, A.;
    • Padilla-González, Y.;
    • García-Chávez, J.;
    • Tripp-Villanueva, F.;
    • Sánchez-Cortés, E.;
    • Ayala-Sánchez, M.;
    • García-León, L. D.;
    • Montiel-Cervantes, L.;
    • Rubio-Borja, M. E.
    Publication type:
    Article
    15